Menu
ncarol.com
  • Home
  • Music
  • Asheville Music
  • Entertainment
  • Business
  • Real Estate
  • Technology
  • Health
  • Books
ncarol.com

First Citizens BancShares Declares Dividends
ncarol.com/10249423

Trending...
  • North Carolina Author Carrie Sybert Celebrates Three Published Books - 151
  • Unlocking the Next Phase of Growth with New AI Innovations; Targeting 2027 as Breakeven; Revenue Momentum Accelerates: ZenaTech (N A S D A Q: ZENA)
  • AeroNet Deploys netElastic vBNG and CGNAT with Tarana Wireless to Deliver Scalable, Fiber-Class Broadband Across Puerto Rico
RALEIGH, N.C., Jan. 26, 2024 /PRNewswire/ -- The Board of Directors (the "Board") of First Citizens BancShares, Inc. ("BancShares") (NASDAQ: FCNCA) declared on Jan. 24, 2024, dividends on the company's Class A and Class B common stock, as well as Series A, B and C preferred stock for the period commencing on and including the last respective payment date.
  • As noted above, the Board declared a quarterly dividend of $1.64 per share on the company's Class A and Class B common stock. The dividend is payable March 15, 2024, to holders of record as of Feb. 29, 2024.
  • The Board declared a regular quarterly dividend of $13.4375 per share on the company's 5.375% non-cumulative perpetual preferred stock, Series A (resulting in a distribution of $0.335938 per depositary share), to be paid on March 15, 2024, to holders of record as of Feb. 29, 2024.
  • The Board declared a dividend of $24.0456 per share on the company's fixed-to-floating rate, non-cumulative perpetual preferred stock, Series B, to be paid on March 15, 2024, to holders of record as of Feb. 29, 2024. BancShares will pay the non-cumulative quarterly cash dividend at a rate of 9.61824%, which is equal to the three-month CME Term Secured Overnight Financing Rate ("SOFR") on the dividend determination date plus the applicable SOFR tenor spread adjustment of 0.26161% and a spread of 3.972%.
  • Also, the Board declared a regular quarterly dividend of $0.351563 per share on the company's 5.625% non-cumulative perpetual preferred stock, Series C, to be paid on March 15, 2024, to holders of record as of Feb. 29, 2024.

ABOUT FIRST CITIZENS BANCSHARES

More on ncarol.com
  • Shelter Structures America backs MATRA Second Life Project to turn retired tent vinyl into homes for displaced families
  • P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
  • Logicraft Launches FuelDeck™, AI That Turns Aviation Fuel Tickets Into One Traceable Ledger
  • Inaugural OC Tech Week Draws 3,000 From 12 Countries, Sends Finalist to $1M Startup World Cup
  • Award-Winning American Hotelier Opens Art-Filled Luxury Cottage in Norfolk, England

First Citizens BancShares, Inc. (NASDAQ: FCNCA), a top 20 U.S. financial institution with more than $200 billion in assets, is the financial holding company for First-Citizens Bank & Trust Company ("First Citizens Bank"). Headquartered in Raleigh, N.C., First Citizens Bank has built a unique legacy of strength, stability and long-term thinking that has spanned generations. First Citizens offers an array of general banking services including a network of more than 500 branches and offices in 30 states; commercial banking expertise delivering best-in-class lending, leasing and other financial services coast to coast; innovation banking serving businesses at every stage; and a nationwide direct bank. Discover more at firstcitizens.com.



Contact:



Deanna Hart

More on ncarol.com
  • Young Author Taraji Jones Surpasses 100 Amazon Book Sales
  • K2 Global / Ozi Amanat Named Among Top 100 AI Venture Capitalists in 2026
  • Dr. Latorial Faison Appointed Poet Laureate of Virginia
  • Nautical Advisory Shares Buyer Perspective in Forbes Agency Council Webinar for Agency Founders
  • AdLeverage Brings Golf Simulator Contest and Home Services Marketing Expertise to Service World Expo 2026



Barbara Thompson




Investor Relations



Corporate Communications




919-716-2137



919-716-2716


SOURCE First Citizens BancShares, Inc.
Filed Under: Business

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • New Finnish Affiliate Site Ilmaiskierrokset.com Puts Wager-Free Spins in the Spotlight
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • Immerse Yourself in the Historic Tochigi Autumn Festival, Celebrated Every Two Years Since 1874
  • Asheville Artist KayeDinero Turns the Blue Ridge Into a Horror Movie With "Halloween"
  • Resident Inspect Expands Virtual Property Inspections With AppFolio and Rentvine Integrations
  • Unlocking the Next Phase of Growth with New AI Innovations; Targeting 2027 as Breakeven; Revenue Momentum Accelerates: ZenaTech (N A S D A Q: ZENA)
  • AeroNet Deploys netElastic vBNG and CGNAT with Tarana Wireless to Deliver Scalable, Fiber-Class Broadband Across Puerto Rico
  • New Atlas Maps the 38 States Behind Every Conversation
  • Atlanta Company Launches Free, Ad-Free, Nonpartisan Voter Planning App for All 50 States Ahead of the Nov. 3 Election
  • NECP Promotes Chertova to Senior Business Analyst
  • Security Industry Veteran Anthony Rumore Launches AegisLead to Help Security Companies Find Business and Manage Growth
  • Charlie Shaw and Patrick Carragher win SEO Agency of the Year 2026
  • Canadian Woman Plants 1,667 Love Stories in a Field of Peonies That Could Bloom for 100 Years
  • Peruvian Gold Wellness Shares Free 2026 Holiday Shopping Guide
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
  • Hall of Fame Speaker Kelly Swanson Competes for National Top Host Title
  • Hall of Fame Speaker Kelly Swanson Launches New Book and Brings Comedy Show to Louisburg, NC
  • North Carolina Author Carrie Sybert Celebrates Three Published Books
  • Access Control Security Shares 5 Ways Retailers Can Prevent Holiday Theft
  • Extreme Lead Program Highlights $27 Real Human Traffic Test for Affiliate and Network Marketers
_catLbl0 _catLbl1

Popular on ncarol.com

  • Constantine "Costa" Kapothanasis II Acquires The Lubri-Loy Company, Carrying a 77-Year-Old American Lubricant Brand Into Its Next Era - 204
  • Parade of Homes Winners Announced - 182
  • LowSignalMail Lets Users Handle Gmail by Text Message - 172
  • North Carolina Author Carrie Sybert Celebrates Three Published Books - 151
  • Remodelers Outstanding Construction Awards Announced - 144
  • Nious Media Expands Independent Entertainment Network Through Gaming, Music and Digital Storytelling - 139
  • RAS AP Consulting Issues National Compliance Alert and Launches Q4 2026 AP Readiness Program Ahead of IRS FIRE → IRIS Cutover - 139
  • Pregis Launches Sharp InfinX: On-Demand Rightsized Mailing System Delivering a Precision-Sized Mailer for Every Order - 131
  • Tulsa Air & Space Museum Launches "Give $16 for the F-16" Challenge to Bring Thunderbird Home for Veterans Day - 129
  • LCM Company Explains Professional Upholstery Cleaning in Charlotte, NC - 119

Similar on ncarol.com

  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Building a Technology Powerhouse-From AI Drones and Global Acquisitions to Defense, Enterprise Software and the Future of Autonomous Operations $ZENA
  • K2 Global / Ozi Amanat Named Among Top 100 AI Venture Capitalists in 2026
  • Pursant Founder Mark Herbick Joins STS Capital Partners as CEO
  • Tampa Web Design Launches New Website for Entrepreneur and Capital Markets Advisor Martin Sumichrast
  • UK Financial Ltd. Announces Maya Preferred PRA as First Fully Verified Asset on MAYA CHAIN; Chainlink Proof of Reserve Integration Planned for Network
  • RAS AP Consulting Advances 1099 Education and Readiness Initiative Through IFOL Training and Finance Technology Showcase
  • Steve Weclew is Appointed by STS Capital Partners as Managing Director
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • Unlocking the Next Phase of Growth with New AI Innovations; Targeting 2027 as Breakeven; Revenue Momentum Accelerates: ZenaTech (N A S D A Q: ZENA)
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute